Many strategies to define desirable standards for laboratory tests to fulfill medical needs have been proposed over the last three decades. Traditional approaches are based on reference (normal) values, opinions of clinicians, the state of the art, views of experts, data on biological variation, and assessment of the effect of error on clinical use. All these approaches have advantages and disadvantages, but the consensus of experts reached over a decade ago that imprecision desirably be less than onehalf of the within-subject biological variation still seems to provide the best set of generally applicable performance standards. Desirable bias is less than one-quarter of the group (within-subject plus between-subject) biological variation. 
However, reference values are available for most quantities, and the formula is simple to apply.
Opinions of clinicians.
In 1968, Barnett (11) proposed "medically significant This has the advantages that it is simple to specify goals from the many external quality-assessment (proficiency testing) schemes in operation, and that such goals are obviously achievable with current technologr. However, it may be that data generated from external qualityassessment schemes do not reflect the performance attained in analyses of samples from patients, because of matrix effects and because some laboratories may go to extraordinary lengths in analyzing samples in these schemes to ensure apparent excellent performance. Moreover, analytical performance changes over time (and not always towards improvement), which will affect what standards are desirable.
Views of individuals
and groups. There are many publications in which views on desirable standards are delineated by individuals or groups (1) (2) (3) (4) . These make for interesting reading but again have the disadvantage that they are subjective in nature. In addition, the expressed views of experts may be contradictory. Biological variation. In the pioneering work on biological variation by Cotlove et al. (16) , they proposed that the tolerable analytical variability should be less than half of the intrinsic biological variation. This approach has some disadvantages but many merits, which are described in detail later.
A landmark in the definition of desirable standards occurred in 1976 when, at the Aspen Conference of the College of American Pathologists, the following recommendations were made (17):
#{149} analytical goals can only be defined in terms of the needs of care of patients #{149} goals for precision and accuracy should be at least as stringent as the current standards of performance; it was proposed that these goals should be achieved by all laboratories by 1980 #{149} for group screening, where the aim is to identify ill individuals in a healthy population, the analytical goal for imprecision is that the CV should be equal to or less than half of the within-subject plus between-subject variation; i.e., CV #{189} (CV2,b + CV2) '&-and this should be the goal for long-term day-to-day laboratory imprecision #{149} for individual single and multipoint testing, the analytical goal is that the CV should be equal to or less than half the within-subject variation; i.e., CV
#{189}
CVb-and this should be the goal for shortterm laboratory imprecision #{149} there is a major requirement for further study of both the statistical relationships that should be used to derive diagnostic information from the results of tests and the physiological and pathophysiological mechanisms that produce variations in particular analytes
The standards derived in this approach generally appear to be based on the studies of biological variation by Statland and Winkel (18 e.g., target value ± 10% for albumin, cholesterol, and total protein; and (c) as the distribution of a survey group, e.g., target value ± 3 SD for thyrotropin. In some cases, more than one set of limits is given, e.g., target value ± 0.33 mniol/L or ± 10% (whichever is greater) for glucose. These PT requirements are the minimum quality requirements that must be satisfied for the laboratory to stay in business (54) 
Concluding Remarks
There has been much work done on the topic of setting desirable standards for laboratory tests to fulfill medical needs. Many of the strategies proposed over the years are now of only historical interest.
In spite of their disadvantages, some are stifi used often; it would be useful if professional bodies, journal editors, and referees of submitted papers assisted in their total demise.
Currently, we think that the advantages of using data on biological variation are so telling that the standards generated from these provide general goals that all laboratories should aim to achieve (57), provided that the following points are borne in mind:
#{149} even when the standards cannot be attained, they should be seen as targets and then design operation process specifications (54) to assure that ongoing analytical performance fulfills medical needs.
Finally, we wonder whether confusion has been caused by the many terms, applied almost interchangeably, to describe desirable performance; such terms include analytical goals, quality goals, quality specifications, and medical needs criteria.
We propose the following terminology to clarify the different situations in which standards are set:
For intralaboratory use:
Quality goals are generally applicable standards for the performance characteristics of tests. They are derived from theoretically valid considerations and are the target specifications required to facilitate the optimum delivery of health care. Such data could be derived in adults quite well from hospital populations, just as population-based reference intervals can be generated from groups of individuals whose disease processes do not affect the quantities in question. However, many children who are hospitalized are really very ill. For many of the quantities studied, they are not approaching health because clinicians are much more discerning about their requests in the pediatric field.
In response to your second question, there are several reasons why one can gain by having performance better than goals. First, if we obtain this desirable perfor-mance standard, 11.8% is added to test result variability through analytical variability.
In some situations, it may be desirable to have an addition of somewhat less. For example,
